BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 33498244)

  • 1. Recent Advances in miRNA Delivery Systems.
    Dasgupta I; Chatterjee A
    Methods Protoc; 2021 Jan; 4(1):. PubMed ID: 33498244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs and Their Big Therapeutic Impacts: Delivery Strategies for Cancer Intervention.
    Holjencin C; Jakymiw A
    Cells; 2022 Jul; 11(15):. PubMed ID: 35954176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in the discovery of microRNA-based anticancer therapeutics: latest tools and developments.
    To KKW; Fong W; Tong CWS; Wu M; Yan W; Cho WCS
    Expert Opin Drug Discov; 2020 Jan; 15(1):63-83. PubMed ID: 31739699
    [No Abstract]   [Full Text] [Related]  

  • 4. Improving miRNA Delivery by Optimizing miRNA Expression Cassettes in Diverse Virus Vectors.
    Herrera-Carrillo E; Liu YP; Berkhout B
    Hum Gene Ther Methods; 2017 Aug; 28(4):177-190. PubMed ID: 28712309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery of therapeutic miRNA using polymer-based formulation.
    Ban E; Kwon TH; Kim A
    Drug Deliv Transl Res; 2019 Dec; 9(6):1043-1056. PubMed ID: 31049843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unified translation repression mechanism for microRNAs and upstream AUGs.
    Ajay SS; Athey BD; Lee I
    BMC Genomics; 2010 Mar; 11():155. PubMed ID: 20205738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent progress in microRNA delivery for cancer therapy by non-viral synthetic vectors.
    Wang H; Jiang Y; Peng H; Chen Y; Zhu P; Huang Y
    Adv Drug Deliv Rev; 2015 Jan; 81():142-60. PubMed ID: 25450259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Getting miRNA Therapeutics into the Target Cells for Neurodegenerative Diseases: A Mini-Review.
    Wen MM
    Front Mol Neurosci; 2016; 9():129. PubMed ID: 27920668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploiting microRNAs As Cancer Therapeutics.
    Robb T; Reid G; Blenkiron C
    Target Oncol; 2017 Apr; 12(2):163-178. PubMed ID: 28138797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Emerging Role of MitomiRs in the Pathophysiology of Human Disease.
    Duarte FV; Palmeira CM; Rolo AP
    Adv Exp Med Biol; 2015; 888():123-54. PubMed ID: 26663182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miRNA Delivery by Nanosystems: State of the Art and Perspectives.
    Moraes FC; Pichon C; Letourneur D; Chaubet F
    Pharmaceutics; 2021 Nov; 13(11):. PubMed ID: 34834316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multiplexed miRNA and transgene expression platform for simultaneous repression and expression of protein coding sequences.
    Seyhan AA
    Mol Biosyst; 2016 Jan; 12(1):295-312. PubMed ID: 26617199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of microRNAs for potential cancer therapeutics.
    Wu W
    Methods Mol Biol; 2011; 676():59-70. PubMed ID: 20931390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. microRNAs in Cardiovascular Disease: Small Molecules but Big Roles.
    Yan B; Wang H; Tan Y; Fu W
    Curr Top Med Chem; 2019; 19(21):1918-1947. PubMed ID: 31393249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applications of nanotechnologies for miRNA-based cancer therapeutics: current advances and future perspectives.
    Bravo-Vázquez LA; Méndez-García A; Rodríguez AL; Sahare P; Pathak S; Banerjee A; Duttaroy AK; Paul S
    Front Bioeng Biotechnol; 2023; 11():1208547. PubMed ID: 37576994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-based therapeutics for cancer.
    Wang V; Wu W
    BioDrugs; 2009; 23(1):15-23. PubMed ID: 19344188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miRNA and cancer; computational and experimental approaches.
    Tutar Y
    Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Embryonic stem cell microRNAs: defining factors in induced pluripotent (iPS) and cancer (CSC) stem cells?
    Gunaratne PH
    Curr Stem Cell Res Ther; 2009 Sep; 4(3):168-77. PubMed ID: 19492978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A perspective to weaponize microRNAs against lung cancer.
    Murugan D; Rangasamy L
    Noncoding RNA Res; 2023 Mar; 8(1):18-32. PubMed ID: 36262424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.